Clinical Trial Update: Serine and Fenofibrate Study in Patients With MacTel Type 2 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating serine and fenofibrate for Macular Telangiectasia Type 2 is ongoing, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Telangiectasia Type

Drugs mentioned

• FENOFIBRATE (Fenofibrate)
• serine (serine)

Snippet

Sponsor: The Lowy Medical Research Institute Limited | Conditions: Macular Telangiectasia Type 2 | Phase 2 | Status: UNKNOWN